Fundz
Real-time · AI · Cross-signal

AATec Medical GmbH just moved. Here's exactly what to do next.

Who to reach, what to say, and why now — on AATec Medical GmbH, plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your planRequest a demo
▶
Watch the 2-minute tour · with sound

AATec Medical and Northway Biotech Form Partnership to Develop Manufacturing Process for ATL-105 Targeting Lung Disease.

Jul 15, 2025•10 months ago

Contract Type

partnership

BiotechnologyHealth CareTherapeutics

Description

AATec Medical and Northway Biotech have announced a strategic partnership to enhance the manufacturing process for ATL-105, aimed at treating non-cystic fibrosis bronchiectasis. Northway Biotech will utilize its manufacturing expertise to develop a scalable production process for this innovative inhaled therapy.

Company Information

Company

AATec Medical GmbH

About

AATec Medical GmbH is a biotech company focused on developing treatments for respiratory diseases. They specialize in a multi-product platform aimed at addressing various respiratory conditions. Their lead product candidate, ATL-105, represents a novel inhaled therapy. AATec is committed to innovation in the field of lung disease treatment.

Predictive Intelligence
Strategic

ML-powered predictions for AATec Medical GmbH's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months